Pulmonary Arterial Hypertension-arkiv - BioStock

Cereno_PhaseIIa_results

Cereno’s phase IIa results positive, clear path forward

3 October, 2024

Cereno vdkommentar

Cereno’s CEO comments on progress with CS1 and CS014

8 July, 2024

Etienne Adriansen CBO Cereno Scientific

Cereno Scientific’s CBO about his new role

7 March, 2023

Fredrik Radencrantz

Iconovo establishes Nordic pharmaceutical sales

5 December, 2022

Cereno Scientific phase II enrolment

First patient enrolled in Cereno Scientific’s phase II study

11 July, 2022

Cereno Scientific solidifies CS1 patent protection in Japan

Cereno Scientific solidifies CS1 patent protection in Japan

25 January, 2022

Cereno Scientific expands patent portfolio

9 September, 2021